Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Davila

Showing results (81-90 of 124) with videos related to

Pageof 13
Sort By:
Blood Advances|July 11, 2022
Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCLAriel Perez, Grace Johnson, Kedar Patel, et al.
Blood|April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaMichael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
BMJ Open|November 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesCaroline Lonez, Bikash Verma, Alain Hendlisz, et al.
Blood|April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Cre-dependent gene expression enables thymic development of autoreactive tumor-associated antigen targeting CAR-T cellsManpreet Bariana, Michael McGuire, Andrea Tuckett, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Frontiers in Immunology|June 6, 2018
VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and RearrangementsScott Christley, Walter Scarborough, Eddie Salinas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
Gastrointestinal Endoscopy|February 10, 2016
Outcome of EMR as an alternative to surgery in patients with complex colon polypsGottumukkala S Raju, Phillip J Lum, William A Ross, et al.
Blood Advances|September 3, 2020
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphomaHamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, et al.
Pageof 13

Showing results (81-90 of 124) with videos related to

Sort By:
Pageof 13
Blood Advances|July 11, 2022
Primary progression during frontline CIT associates with decreased efficacy of subsequent CD19 CAR T-cell therapy in LBCLAriel Perez, Grace Johnson, Kedar Patel, et al.
Blood|April 27, 2022
Whole-genome sequencing reveals complex genomic features underlying anti-CD19 CAR T-cell treatment failures in lymphomaMichael D Jain, Bachisio Ziccheddu, Caroline A Coughlin, et al.
BMJ Open|November 15, 2017
Study protocol for THINK: a multinational open-label phase I study to assess the safety and clinical activity of multiple administrations of NKR-2 in patients with different metastatic tumour typesCaroline Lonez, Bikash Verma, Alain Hendlisz, et al.
Blood|April 14, 2021
Interventions and outcomes of adult patients with B-ALL progressing after CD19 chimeric antigen receptor T-cell therapyKitsada Wudhikarn, Jessica R Flynn, Isabelle Rivière, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 25, 2025
Cre-dependent gene expression enables thymic development of autoreactive tumor-associated antigen targeting CAR-T cellsManpreet Bariana, Michael McGuire, Andrea Tuckett, et al.
Transplantation and Cellular Therapy|July 5, 2026
System-Level Redesign of an Allogeneic Hematopoietic Cell Transplantation Program Associated with High 1-Year Survival and Reduced CostShernan G Holtan, Megan M Herr, Kanwal Mallhi, et al.
Frontiers in Immunology|June 6, 2018
VDJServer: A Cloud-Based Analysis Portal and Data Commons for Immune Repertoire Sequences and RearrangementsScott Christley, Walter Scarborough, Eddie Salinas, et al.
International Journal of Radiation Oncology, Biology, Physics|June 9, 2019
Radiation Therapy as a Bridging Strategy for CAR T Cell Therapy With Axicabtagene Ciloleucel in Diffuse Large B-Cell LymphomaAustin J Sim, Michael D Jain, Nicholas B Figura, et al.
Gastrointestinal Endoscopy|February 10, 2016
Outcome of EMR as an alternative to surgery in patients with complex colon polypsGottumukkala S Raju, Phillip J Lum, William A Ross, et al.
Blood Advances|September 3, 2020
Venous thromboembolism associated with CD19-directed CAR T-cell therapy in large B-cell lymphomaHamza Hashmi, Abu-Sayeef Mirza, Alicia Darwin, et al.
Pageof 13